Synopsys, Inc. $SNPS Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. trimmed its holdings in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 70.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 53,312 shares of the semiconductor company’s stock after selling 126,312 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Synopsys were worth $26,304,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of SNPS. Stanley Laman Group Ltd. boosted its holdings in shares of Synopsys by 542.9% during the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after acquiring an additional 10,874 shares during the period. Symphony Financial Ltd. Co. lifted its position in Synopsys by 4,780.9% in the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after purchasing an additional 39,395 shares during the last quarter. HBW Advisory Services LLC boosted its stake in Synopsys by 494.9% during the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock valued at $1,851,000 after purchasing an additional 3,004 shares during the period. Bank of New York Mellon Corp grew its position in Synopsys by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock worth $691,035,000 after purchasing an additional 4,815 shares during the last quarter. Finally, Westbourne Investments Inc. bought a new stake in shares of Synopsys during the second quarter valued at approximately $1,505,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Synopsys Price Performance

NASDAQ:SNPS opened at $519.70 on Thursday. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The business’s 50-day moving average price is $442.21 and its 200 day moving average price is $503.94. The firm has a market cap of $99.43 billion, a P/E ratio of 65.04, a PEG ratio of 4.23 and a beta of 1.12.

Synopsys (NASDAQ:SNPSGet Free Report) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same period in the previous year, the firm earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, sell-side analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.62% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on SNPS shares. Robert W. Baird reissued a “neutral” rating and issued a $535.00 price objective (down from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Baird R W cut Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 10th. Mizuho cut their price objective on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating on the stock in a research note on Thursday, September 11th. Wells Fargo & Company increased their target price on shares of Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a research report on Thursday, December 11th. Finally, Needham & Company LLC raised their target price on shares of Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Eleven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $562.13.

Get Our Latest Stock Analysis on Synopsys

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.